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Abstract
Background: 2-Methylthioadenosine 5'-triphosphate (2-MeSATP), formerly regarded as a specific
P2Y (metabotropic) purinergic receptor agonist, stimulates Ca2+ influx and evokes catecholamine
release from adrenal chromaffin cells. These cells express P2Y and P2X (ionotropic) purinoceptors,
with the latter providing an important Ca2+ influx pathway. Using single cell calcium imaging
techniques, we have determined whether 2-MeSATP might be a specific P2X receptor agonist in
bovine chromaffin cells and assessed the relative role of P2X and P2Y receptors on catecholamine
secretion from these cells.
Results: ATP raised the [Ca2+]i in ~50% of the cells. Removing extracellular Ca2+ suppressed the
[Ca2+]i-raising ability of 2-MeSATP, observed in ~40% of the ATP-sensitive cells. This indicates that
2-MeSATP behaves as a specific ionotropic purinoceptor agonist in bovine chromaffin cells. The 2-
MeSATP-induced [Ca2+]i-rises were suppressed by PPADS. UTP raised the [Ca2+]i in ~40% of the
ATP-sensitive cells, indicating that these expressed Ca2+-mobilizing P2Y receptors. UTP-sensitive
receptors may not be the only P2Y receptors present, as suggested by the observation that ~20%
of the ATP-sensitive pool did not respond to either 2-MeSATP or UTP. The average sizes of the
ATP- and 2-MeSATP-evoked [Ca2+]i responses were identical in UTP-insensitive cells. 2-MeSATP
stimulated Ca2+ influx and evoked catecholamine release, whereas UTP elicited Ca2+ release from
intracellular stores but did not evoke secretion. 2-MeSATP-induced secretion was strongly
inhibited by Cd2+ and suppressed by extracellular Ca2+ or Na+ removal. TTX inhibited 2-MeSATP-
evoked secretion by ~20%.
Conclusion: 2-MeSATP is a specific P2X purinoceptor agonist and a potent secretagogue in
bovine chromaffin cells. Activation of 2-MeSATP-sensitive receptors stimulates Ca2+ influx mainly
via voltage-sensitive Ca2+ channels. For the most part, these are activated by the depolarization
brought about by Na+ influx across P2X receptor pores.
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Background
Extracellular ATP plays an important role in catecho-
lamine release from adrenal chromaffin cells, either facil-
itating cholinergic stimulation via ionotropic (P2X)
purinoceptors or inhibiting evoked release through a
delayed action on metabotropic (P2Y) purinoceptors (see
[1] and references therein). The latter may provide the
basis for an auto-inhibitory feedback loop involving both
autocrine and paracrine interactions. There are at least
seven P2X receptor subunits encoded by distinct genes,
which may form homo- or heterotrimeric ionotropic puri-
noceptors; functional P2X receptors are Ca2+-permeable
and provide an important Ca2+ influx pathway, both in
neurons and other cell types (for review see [2,3]).
The presence of P2X receptor subtypes in chromaffin cells
is species-dependent [4] (see [3] for a review). Thus, rat
chromaffin cells have either been reported to lack P2X
receptors [4] or to show a variable expression of P2X
receptor subtypes (P2X1, P2X2, P2X5 and P2X7) [5,6];
there is also some evidence that these cells express P2X4
receptors in aged animals [7]. Guinea-pig chromaffin cells
seem to express P2X6 receptors [8], although functional
studies point strongly to the presence of P2X2-like recep-
tors [4]. There are no studies reporting the expression of
specific P2X receptor subtypes in bovine chromaffin cells.
However, the presence of P2X receptors in these cells has
been suggested by functional studies involving mostly
cytosolic free Ca2+  measurements [9-11]. ATP-evoked
inward currents have been detected in a limited fraction of
the cells [12]. The prevailing P2Y receptor subtype in
bovine chromaffin cells seems to be an UTP-sensitive, Gi/
o-coupled P2Y receptor [1,10,13].
ATP and other purinergic agonists evoke catecholamine
release from either whole glands or isolated chromaffin
cells [9,10,14]. This action is strictly Ca2+-dependent, sug-
gesting that it might be mediated by either Ca2+ influx
through the receptor-associated pores, opening of voltage-
sensitive Ca2+ channels or both. Studying P2X receptor-
mediated modulation of chromaffin cell function has
been made difficult by the lack of specific agonists and
antagonists of P2X receptor subtypes. 2-MeSATP, for
example, has been classically regarded as a P2Y receptor
agonist; more recently, however, several P2Y receptor sub-
types have been found to be insensitive to the ATP deriv-
ative [2,3]. Moreover, 2-MeSATP is now known to activate
P2X receptor subtypes [15]. There is evidence that 2-
MeSATP behaves as a P2X agonist in guinea-pig chromaf-
fin cells, as assessed by its ability to evoke inward currents
[4,16]. Previous studies provided conflicting evidence
regarding the action of 2-MeSATP on cytosolic free Ca2+
concentration ([Ca2+]i) in bovine chromaffin cells, with
one study reporting sizeable responses [11] and another
feeble and sporadic responses [9]. Whether 2-MeSATP
might discriminate between P2X and P2Y receptors in
chromaffin cells remains unknown.
In this work, we aimed at establishing 2-MeSATP as a spe-
cific P2X receptor agonist in bovine chromaffin cells by
single-cell calcium imaging. We then investigated the
effects of 2-MeSATP and UTP on catecholamine release,
aiming at clarifying the relative role of P2X and Ca2+-
mobilizing P2Y receptors.
Results
[Ca2+]i rises evoked by purinoceptor agonists
[Ca2+]i changes evoked by ATP receptor agonists were
monitored by digital fluorescence imaging of the F340/F380
fura-2 fluorescence ratio (∆R). Only cells that displayed
sizeable [Ca2+]i responses to 10 µM 1,1-dimethyl-4-phe-
nylpiperazinium iodide (DMPP), an established agonist
of acetylcholine nicotinic receptors in chromaffin cells,
were considered for the study. To this end, cells were per-
ifused at the tail of the experiments with 10 µM DMPP for
brief periods of time. Our first basic protocol was to stim-
ulate chromaffin cells with ATP, UTP and 2-MeSATP in
order to investigate whether UTP-sensitive cells might also
be sensitive to 2-MeSATP. Cells were typically subjected to
~60 s pulses of solutions containing each purinoceptor
agonist and washed extensively for at least 10 min to min-
imize receptor desensitization at the time of the next chal-
lenge.
Typical pseudocolor fura-2 fluorescence images are
depicted in Fig. 1(A–D). Representative time courses of
[Ca2+]i changes for selected chromaffin cells are depicted
in E. Resting [Ca2+]i was low prior to stimulation (A, blue).
Challenging cells with 100 µM ATP elicited sizeable, albeit
variable peak [Ca2+]i responses from a large pool of chro-
maffin cells (B and E; green, yellow or red). It is notewor-
thy that some cells did not respond to ATP (e.g. cell 4).
Several cells (e.g. cell 1) exhibited pronounced [Ca2+]i
rises in response to ATP but not 100 µM UTP. Exposure to
100  µM 2-MeSATP invariably increased the [Ca2+]i  in
these cells. In contrast, several cells (e.g. cell 2) responded
to both ATP and UTP. For the most part these cells did not
respond at all to 2-MeSATP. A fraction of the ATP-sensitive
cells responded both to UTP and 2-MeSATP (e.g. cell 3).
The statistical assessment of the [Ca2+]i responses of chro-
maffin cells to UTP and 2-MeSATP is presented in Fig. 1F
in the form of a 3D histogram. The column at the origin
of the histogram (blue) depicts cells that did not respond
both to UTP and 2-MeSATP (137 in 234 cells, i.e. 59%);
ATP evoked [Ca2+]i rises in 27 of these cells. Cells display-
ing a variable response to 2-MeSATP and no UTP response
(orange) accounted for approximately 30% of the ATP-
sensitive pool; the mean size of the 2-MeSATP-evoked
[Ca2+]i responses was not significantly different from theBMC Neuroscience 2007, 8:41 http://www.biomedcentral.com/1471-2202/8/41
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ATP responses in these cells (1.53 ± 1.22 vs. 1.55 ± 1.18,
respectively; n = 37 cells, p = 0.8). UTP-sensitive cells
(green) were for the most part (approximately 40% of the
ATP-sensitive pool) insensitive to 2-MeSATP, although a
minority (ca. 8%, yellow) displayed a mixed sensitivity.
The mean sizes of the UTP and ATP responses in UTP-sen-
sitive/2-MeSATP-insensitive cells were 0.71 ± 0.61 and
0.92 ± 0.73, respectively (n = 49 cells; statistically differ-
ent, p < 0.0001).
None of the cells responding to 2-MeSATP in presence of
Ca2+ responded in the virtual absence of extracellular Ca2+
(Fig. 2A,B,E), suggesting that the ATP derivative is a spe-
cific P2X receptor agonist in bovine chromaffin cells. We
have previously reported that suramin blocked the ATP-
evoked [Ca2+]i responses in cells lacking ATP responses in
the virtual absence of extracellular Ca2+; suramin did not
affect the UTP responses, suggesting that it behaves as a
Effects of PPADS and extracellular Ca2+ removal on calcium  responses to 2-MeSATP Figure 2
Effects of PPADS and extracellular Ca2+ removal on 
calcium responses to 2-MeSATP. A-B. Calcium images 
showing a group of chromaffin cells during stimulation with 
20 µM 2-MeSATP in presence of extracellular calcium (A) 
and during stimulation in the virtual absence of extracellular 
calcium ("2-MeSATP +EGTA", B); C-D. The cells were sub-
sequently superfused with a Ca2+-containing solution and 
challenged with 2-MeSATP, in the absence (C) or presence 
of 50 µM PPADS ("2-MeSATP +PPADS", D). Calibration bar: 
50 µm. More in the legend to Fig. 1(A-D); E. Time courses of 
changes in F340/F380 fluorescence ratio for two representative 
cells (cells 1 and 2, also depicted in A-D). The lines denote 
superfusions with 2-MeSATP, PPADS or EGTA-containing 
solution. The responses are representative of data from 3 
experiments.
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Calcium responses to ATP, UTP and 2-MeSATP Figure 1
Calcium responses to ATP, UTP and 2-MeSATP. A-D. 
Calcium images showing a group of chromaffin cells before (A, 
"control") and during stimulation with 100 µM ATP (B), 100 
µM 2-MeSATP (C) and 100 µM UTP (D). At the end of each 
experiment cells were stimulated with 10 µM DMPP. Cells 
were allowed to rest for ~10 min between consecutive stimu-
lations. The fura-2 fluorescence ratio F340/F380 was determined 
for each cell in a field on a pixel-by-pixel basis. Images were 
coded in pseudocolor to show differences in the F340/F380 
ratio. The images corresponding to agonist stimulation (B-D) 
were captured at the response peaks. Calibration bar: 50 µm; 
E. Time courses of changes in F340/F380 fluorescence ratio for a 
2-MeSATP-sensitive/UTP-insensitive cell (cell 1), an UTP-sensi-
tive/2-MeSATP-insensitive cell (cell 2), a cell displaying a mixed 
response (cell 3) and an ATP-insensitive cell (cell 4). The lines 
denote superfusions with DMPP or purinergic agonists. Some 
of the peak responses to DMPP were truncated for scaling 
reasons; F. Frequency distribution histogram of calcium 
responses. Changes in ∆R = F340/F380 were determined from 
the experiment depicted in A-D and 2 similar experiments (n 
= 234 cells). The column at the origin represents cells that did 
not respond to either UTP or 2-MeSATP (∆R < 0.5, n = 137 
cells). This column was truncated for scaling reasons. Columns 
in orange: cells responding to 2-MeSATP only; columns in 
green: cells responding to UTP only; columns in yellow: cells 
exhibiting mixed responses.
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specific P2X receptor antagonist [10]. We have now
extended this conclusion to pyridoxalphosphate-6-azo-
phenyl- 2',4'-disulphonic acid (PPADS, 50 µM). Indeed,
the drug blocked the 2-MeSATP (20 µM)-evoked [Ca2+]i
rises in all cells tested (n = 9 cells; Fig. 2C,D,E). Moreover,
in parallel experiments, PPADS did not affect the UTP-
evoked [Ca2+]i rises in cells displaying no response to 2-
MeSATP (0.69 ± 0.33 vs. 0.73 ± 0.32 in absence of PPADS;
n = 11 cells, p = 0.1).
Effects of purinergic agonists on catecholamine secretion
Both ATP and 2-MeSATP evoked catecholamine secretion
in a dose-dependent way, as assessed amperometrically
from cell batches (Fig. 3A). In these experiments cells were
challenged with brief pulses of either agonist at increasing
concentrations, being allowed to rest for ~10 min between
successive applications. The concentration-response
curves provided in Fig. 3B suggest that 2-MeSATP might
be a more potent agonist for purinergic receptors (EC50 =
3.1 µM vs. 7.7 µM for ATP; but see the Discussion section
for a critical assessment of this hypothesis). (Concentra-
tions of test agents are henceforth given as nominal con-
centrations. Actual concentrations at the cell bed differ
from nominal concentrations by a factor of 1.64, see
Methods and legend to Fig. 3.) UTP (100 µM) did not
evoke catecholamine secretion. PPADS (50 µM) abol-
ished 2-MeSATP (10 µM)-evoked secretion (Fig. 3B).
Challenging the cells with 50 µM 2-MeSATP in the virtual
absence of extracellular calcium failed to elicit secretion
(Fig. 3B), indicating that the stimulatory action of the
purinoceptor agonist is strictly calcium-dependent. This
action may be mediated mostly by activation of voltage-
sensitive Ca2+ channels, since 0.5 mM Cd2+ (a blocker of
these channels) reduced 2-MeSATP-evoked secretion by
73.0 ± 1.5% (n = 3 experiments); Cd2+ inhibited high K+
(50 mM)-evoked catecholamine secretion by ~98% (n = 3
experiments). Replacing extracellular Na+ for N-methyl-D-
glucamine (NMG+) abolished 2-MeSATP-evoked secre-
tion (Fig. 3B); tetrodotoxin (TTX, 1 µM) had a modest
(18.5 ± 3.0%, n = 3 experiments) inhibitory effect on
evoked secretion, suggesting that Na+ influx through TTX-
sensitive, voltage-dependent Na+ channels played a mini-
mal role.
Discussion
We found that ~50% of the cells examined by fluores-
cence imaging exhibited [Ca2+]i responses to ATP and that,
among these, ~40% yielded positive responses to 2-
MeSATP. None of the 2-MeSATP-sensitive cells responded
in the virtual absence of extracellular Ca2+. Since cell expo-
sure to EGTA-containing solutions caused minimal deple-
tion of intracellular Ca2+ stores [1,10], this implies that 2-
MeSATP elicits [Ca2+]i rises by stimulating Ca2+ influx.
Hence, 2-MeSATP behaves as a specific P2X receptor ago-
nist in bovine chromaffin cells.
The 2-MeSATP-sensitive P2X receptors in these cells are
blocked by low concentrations of suramin [10] and
PPADS (this work). In agreement with a previous study
[9], we show here that 2-MeSATP is a stronger secreta-
gogue than ATP. This might suggest that ATP is a weaker
agonist of the P2X receptor, in apparent disagreement
with the information provided by our former [Ca2+]i study
[11] where the order of potency for purinergic agonists
was ATP > 2-MeSATP >> αβ-MeATP, ADP [βS], AMP. We
Effects of 2-MeSATP and ATP on catecholamine release Figure 3
Effects of 2-MeSATP and ATP on catecholamine 
release. A. Amperometric currents recorded from chroma-
ffin cell batches in response to brief pulses of increasing 2-
MeSATP and ATP concentrations. Cells were allowed to rest 
for ~10 min between successive applications. Nominal ago-
nist concentrations (in µM) are indicated beneath each trace. 
Nominal concentrations of test agents are used throughout 
this legend. Actual concentrations at the cell bed differ from 
nominal concentrations by a factor of 1.64 (see Methods). 
Concentrations along the X axis in Fig. 3B are actual concen-
trations at the cell bed; B. Dose-response curves of catecho-
lamine release evoked by 2-MeSATP and ATP (circles and 
squares, respectively). Data from the experiment depicted in 
A and two similar experiments. Also depicted are data for 
UTP (100 µM; filled square) as well as for 2-MeSATP stimula-
tions in presence of 50 µM PPADS (diamond), in the virtual 
absence of extracellular Ca2+ (EGTA-containing solution, 
inverted triangle) and in absence of extracellular Na+ (Na+ 
replacement for NMG+, triangle) (n = 3 experiments for each 
condition).
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note, however, that activation of a P2Y receptor coupled
to Gi/o inhibits exocytotic release of catecholamines from
rat chromaffin cells downstream voltage-sensitive Ca2+
channels and cytosolic Ca2+  elevation [17]. Moreover,
activation of P2Y receptors inhibits voltage-sensitive Ca2+
channels via Gi/Go proteins and, thus, depresses Ca2+-
dependent exocytosis [12,13,18-22]. Subclassification of
P2X receptors in bovine chromaffin cells was clearly out-
side the objectives of the present functional study. None-
theless, taking into account the sensitivity to inhibitors, as
well as the above order of potency for purinergic agonists,
P2X receptors expressed in bovine chromaffin cells appear
to have the pharmacological profile of P2X2  or
P2X5receptors [2,4,15]. As a note of caution we emphasize
that P2X receptors in situ most probably are composed of
different unit subtypes with a pharmacology distinct from
that of the homomeric receptors cloned and transfected to
cells, which difficults any attempt at identifying P2X
receptor subtypes on the basis of functional studies.
We have also found that ~50% of the ATP-sensitive cells
yielded positive responses to UTP. Thus, since UTP is a
specific agonist for P2Y receptors in bovine chromaffin
cells [1], approximately half of the ATP-sensitive cell pop-
ulation expressed functional Ca2+-mobilizing P2Y recep-
tors. This agrees with the finding by Ennion et al. that
these cells express an as yet unidentified UTP-sensitive, Gi/
o-coupled P2Y receptor [13]. It is noteworthy that the
authors also provided evidence for the presence of a Gi/o-
linked, adenine nucleotide-specific P2Y12  receptor and
detected transcripts for P2Y1 receptors by RT-PCR analysis.
Accordingly, our results suggest that bovine chromaffin
cells express a Ca2+-mobilizing, UTP-insensitive P2Y
receptor. Indeed, ~20% of the ATP-sensitive pool did not
respond to either 2-MeSATP or UTP. Taking into account
that P2X receptors are fully sensitive to 2-MeSATP in
bovine chromaffin cells, the most likely explanation for
this finding is that, indeed, some cells express a Ca2+-
mobilizing, UTP-insensitive P2Y receptor.
Chromaffin cells exist in the form of two major pheno-
types, epinephrine-secreting (adrenergic) and norepine-
phrine-secreting (noradrenergic) cells [23]. Our previous
work [1] showed that P2X receptors and UTP-sensitive
P2Y receptors are asymmetrically distributed among two
distinct cell pools (noradrenergic and adrenergic cells).
The present data are fully compatible with this finding.
Indeed, approximately 30% of the ATP-sensitive cells
yielded positive responses to 2-MeSATP but not to UTP,
suggesting that they express P2X receptors preferentially.
Moreover, approximately 40% of the ATP-sensitive cells
yielded positive responses to UTP but not to 2-MeSATP,
suggesting that they express Ca2+-mobilizing P2Y recep-
tors only. A small fraction of the ATP-sensitive cells exam-
ined in this study responded both to UTP and 2-MeSATP,
suggesting that they co-express P2X and P2Y receptors (see
also [10]).
There is evidence that stimulated Ca2+ influx is strongly
coupled to catecholamine release; in contrast, Ca2+ release
from intracellular stores appears to be loosely coupled to
secretion [10,24]. The present data support this concept,
inasmuch as P2X receptor activation by 2-MeSATP stimu-
lated Ca2+  influx and evoked catecholamine release,
whereas activation of P2Y receptors by UTP elicited Ca2+
release from intracellular stores but did not evoke secre-
tion. We found that, while 2-MeSATP-induced secretion
was strictly Na+-dependent, the voltage-sensitive Na+
channel blocker TTX [25,26] inhibited evoked release by a
modest 20%. This suggests that voltage-sensitive Ca2+
channels were mostly activated by the depolarization
brought about by Na+ influx across P2X receptor pores.
That voltage-sensitive Ca2+ channels are involved in 2-
MeSATP-induced secretion is suggested by the strong
inhibitory effect of Cd2+. Indeed, Cd2+ blocks Ca2+ influx
across these channels without affecting P2X receptors
[27,28].
Conclusion
2-MeSATP is a specific P2X purinoceptor agonist and a
potent secretagogue in bovine chromaffin cells. Activation
of P2X receptors stimulates Ca2+ influx mainly via voltage-
sensitive Ca2+ channels. For the most part, these are acti-
vated by the depolarization brought about by Na+ influx
across P2X receptor pores.
Methods
Cell culture
Bovine adrenal glands were obtained from the local
slaughterhouse and kept on ice during transportation.
Adrenal medulla cells were isolated by collagenase diges-
tion of the glands and purified on a Percoll density gradi-
ent essentially as described previously [29,30]. The
purified cell fraction thus obtained is enriched in chroma-
ffin cells. Cells were cultured according to established pro-
cedures [1]. For the fluorescence imaging experiments, the
cells were plated on round (16 mm diameter) glass cover-
slips coated with poly-L-lysine. For the secretion experi-
ments, the cells were cultured in 60 mm diameter plastic
Petri-dishes. Cells were typically used between days 2 and
5 after plating.
Solutions
The Ca2+-containing salt solution used in the imaging and
secretion experiments had the following composition
(mM): 140 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 mM HEPES
and 10 glucose (pH 7.4). In some experiments extracellu-
lar free [Ca2+] was buffered at 100 nM by mixing appropri-
ate amounts of Ca2+ and EGTA, as described elsewhere
[31].BMC Neuroscience 2007, 8:41 http://www.biomedcentral.com/1471-2202/8/41
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[Ca2+]i imaging
The coverslips containing the cells were washed in physi-
ological saline supplemented with 1% bovine serum albu-
min (BSA). The cells were then loaded with 2.5 µM fura-
2/AM (the acetoxymethyl ester of fura-2 [32]) for 45 min
at 37°C in this medium, under a 95% O2/5% CO2 atmos-
phere. Cell handling after loading was carried out follow-
ing established procedures. Specifically, cells were
continuously perifused (approximately 1.5 ml/min) with
physiological saline at room temperature. Solution
exchange was provided by a four-way stopcock valve
located near the recording chamber [1,10,11]. Fluores-
cence changes were recorded using a multiple excitation
MagiCal imaging system (Applied Imaging, U.K.), essen-
tially as described [1,33].
Catecholamine secretion
Catecholamine secretion from chromaffin cells was meas-
ured on-line using a perifusion system similar to that
described previously [34]. Approximately 106 cells were
placed in a 0.45 µm flow filter and perifused with the
HEPES-containing solution with the aid of a peristaltic
pump (Gilson Miniplus 3) at a rate of 1 ml/min. Test
drugs were added as brief pulses through a 500-µl loop
injector. Taking into account the dead volume of the filter
chamber and the flow rate, the actual concentration of a
given drug inside the chamber (cell bed) was reduced by
a factor of 1.64. Thus, while drug concentrations are given
as nominal concentrations throughout the main text and
legend to Fig. 3, the concentrations along the X axis in Fig.
3B are corrected for the dilution factor (i.e. they refer to
the actual concentrations acting on cells). The effluent
solution exiting the filter was driven into an electrochem-
ical detector (set at +500 mV, Omni 90 Potentiostat,
Cypress Systems, Lawrence, KS) for direct measurement of
catecholamine oxidation current, which was monitored
on a chart recorder.
Data analysis
Data are presented as mean ± S.D. Statistical significance
of differences was assessed by paired (within the same
experiment) or unpaired (between experiments) Student's
t-test; differences were considered significant at the 95%
confidence level (P < 0.05).
Other materials
Fura-2/AM was from Molecular Probes (Eugene, Ore.,
USA). ATP was from Boehringer (Mannheim, Germany).
Unless otherwise specified, all other chemicals were from
Sigma Chemical Co. (St. Louis, Mo., USA).
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